Pilot Trial of Hibiscus Drink During Pregnancy (PTHDDP)
NCT ID: NCT07175597
Last Updated: 2025-09-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
10 participants
INTERVENTIONAL
2024-04-30
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Is the drink acceptable to take as a daily dose for a long time? Does drinking the beverage cause negative effects? What is the effect of drink consumption on blood pressure and biomarkers in pregnant women?
Each participant was their own control with the values measured before consumption of the beverage and after four weeks of consumption.
The participants:
* Took a daily dose of the beverage for 4 weeks
* Once a week for the four weeks, they answered the acceptability and tolerability questionnaires
* Before starting to consume the beverage and after the 4 weeks of consumption, they had their blood pressure measured, and samples taken for biomarker measurements.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
NCT04356326
Hydroxychloroquine in Type 2 Diabetes During Pregnancy
NCT06319560
Hypertension In Postpartum Preeclampsia Study
NCT03011567
Postpartum Management of Hypertension in Pregnancy With Hydrochlorothiazide
NCT03298802
NSAID Use in Postpartum Hypertensive Women
NCT02902172
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
SCREENING
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pregnant women
Pregnant women in the second trimester of pregnancy who consumed a daily dose of Hibiscus sabdariffa drink for 4 weeks
Hibiscus sabdariffa drink
A daily dose of Hibiscus sabdariffa drink that provides 9.6 mg of anthocyanins
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hibiscus sabdariffa drink
A daily dose of Hibiscus sabdariffa drink that provides 9.6 mg of anthocyanins
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 to 35 years
* Blood pressure \<140/90 mmHg
Exclusion Criteria
* Hypertensive disorder in previous pregnancies
* Body mass index \>32 kg/m2
* Present chronic diseases
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Polytechnic Institute, Mexico
OTHER
Victor Eduardo Alcantar Rodríguez
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Victor Eduardo Alcantar Rodríguez
Associate Research Professor B
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Victor E. Alcantar Rodríguez, PhD Student
Role: PRINCIPAL_INVESTIGATOR
National Polytechnic Institute and Autonomous University of Barcelona
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
MEDOMAI
Cuernavaca, Morelos, Mexico
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IPNMexico
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.